A randomized trial for the treatment of refractory status epilepticus

Rossetti, Andrea O; Milligan, Tracey A; Vulliémoz, Serge; Michaelides, Costas; Bertschi, Manuel; Lee, Jong Woo (2011). A randomized trial for the treatment of refractory status epilepticus. Neurocritical care, 14(1), pp. 4-10. New York, N.Y.: Springer 10.1007/s12028-010-9445-z

Full text not available from this repository. (Request a copy)

Refractory status epilepticus (RSE) has a mortality of 16-39%; coma induction is advocated for its management, but no comparative study has been performed. We aimed to assess the effectiveness (RSE control, adverse events) of the first course of propofol versus barbiturates in the treatment of RSE.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Bertschi, Manuel

ISSN:

1541-6933

Publisher:

Springer

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:26

Last Modified:

17 Mar 2015 21:09

Publisher DOI:

10.1007/s12028-010-9445-z

PubMed ID:

20878265

Web of Science ID:

000286394300002

URI:

https://boris.unibe.ch/id/eprint/9458 (FactScience: 215195)

Actions (login required)

Edit item Edit item
Provide Feedback